I know, I know. I used that title before, but it’s so good, I’m going to use it again. Anyway, back on July 15th, I suggested Humana (HUM) as a short, since it had filled its gap so nicely.

I’d say it worked out, eh?
Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
I know, I know. I used that title before, but it’s so good, I’m going to use it again. Anyway, back on July 15th, I suggested Humana (HUM) as a short, since it had filled its gap so nicely.

I’d say it worked out, eh?
On Monday, well in advance of this week’s absolutely insanity, I suggested going short Brazil by way of EWZ. I’m pleased to say, in spite of all the lifetime highs everywhere we look, this worked out great.

I first mentioned Oscar Health (OSCR) in February, and I’ve done about ten posts about it this year. It continues to do nicely, and on a day like this, I don’t even want to THINK about any shorts.

At the start of this month, I did this post which set about on an experiment. Specifically, I wanted to see if I put $10,000 into 25 historically very bullish stocks (what I call perma-risers) how they would do.
Well, the results are oddly satisfying, because so far, a couple of weeks into this experiment, they haven’t done a THING. Indeed, with the Dow at lifetime highs today, this portfolio is actually down about 0.5%. I think this simply illustrates, with a near-even split of winners and losers, and a net loss, that the breadth of this “bull” market absolutely stinks.
